Stock analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research report issued on Saturday. The firm set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE CO opened at $1.75 on Friday. The stock’s 50-day moving average is $1.56 and its two-hundred day moving average is $1.36. The company has a market cap of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. Global Cord Blood has a 1-year low of $2.03 and a 1-year high of $5.50.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- How to Calculate Stock Profit
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Stock Dividend Cuts Happen Are You Ready?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Manufacturing Stocks Investing
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.